CASE STUDY Animal origin–free reagents Breaking new ground on animal origin–free reagents Capabilities Capabilities at Thermo Fisher Scientific that power project success: • Decades of experience developing and manufacturing enzymes and nucleotides at scale for life science products, including through the use of in vitro molecular evolution, synthetic biology, and in vitro translation • 2010 acquisition of Fermentas in Vilnius, Lithuania, led to expanded molecular biology enzyme production capabilities and expertise • Anticipating the market need for AOF reagents, the OEM and Commercial Supply team at Thermo Fisher Scientific had already begun investing in R&D towards AOF enzyme production capabilities • Rapidly forming and expanding a dedicated R&D team to accelerate AOF

Join for free to read